Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals
Clinical trial NCT02958982 · TERMINATED
Trial details
- NCT number
- NCT02958982
- Sponsor
- Rhizen Pharmaceuticals SA
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-03
- Primary completion
- 2018-02-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.